Clinical Trial

A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Japan.

Study acronym: HIZ
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A study to evaluate the safety of Hympavzi under the actual use in patients with congenital hemophilia who do not have inhibitors.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-02; most recent amendment 2026-03-24.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-11-19
Trial Details
NCT Number NCT07161687
Lead Sponsor Pfizer
Conditions Hemophilia A or B
Enrollment 50 participants
Start Date 2025-10-30
Primary Completion 2030-04-11 (estimated)
Study Completion 2030-04-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-30